Can the Activity of Macrophages Predict Response to TVEC in Melanoma?
The activity of macrophages may be used to predict whether a melanoma patient will respond to immunotherapy, according to a study in JCO Oncology Advances. For the study, researchers examined novel biomarkers that may identify melanoma patients more likely to respond to talimogene laherparepvec (TVEC). TVEC is a modified oncolytic virus that is injected into […]